Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings. Their latest moves can shine a bright light on smart stock picks.
Today let's look at money managers Douglas C. Lane & Associates, founded in 1994 and based in New York City. The firm devotes a high-profile section of its website to its unofficial mascot, the turtle, chosen for its willingness to stick its neck out and its perseverance, among other things. A profile in Barron's summarized its investment strategy by noting that "the firm invests long-only, aims for low portfolio turnover, and takes a long-term view -- typically three to five years -- of securities." Between 1994 and now, the money it manages for clients has grown from $300 million to about $3 billion, which suggests that the firm is doing something right.
The company's reportable stock portfolio totaled $2.6 billion �in value as of June 30.
Interesting developments
So what does Douglas C. Lane's latest quarterly 13F filing tell us? Here are a few interesting details.
Top 10 Undervalued Stocks To Watch For 2015: Ingram Micro Inc. (IM)
Ingram Micro Inc. distributes information technology (IT) products; and provides supply chain solutions, mobile device lifecycle services, and logistics solutions worldwide. The company�s IT peripherals include printers, scanners, displays, projectors, monitors, panels, mass storage, and tape; large format LCD and plasma displays, enclosures, mounts, media players, content software, and content creation and hosting; mobile phones, digital cameras and video disc players, game consoles, televisions, audio, media management, and home control products; barcode/card printers, AIDC scanners and software, and wireless infrastructure products; IP video surveillance, security and fire alarm systems, and access control smart cards; processors, motherboards, hard drives, and memory products; and ink and toner supplies, paper, carrying cases, and anti-glare screens. It also provides various systems, including rack, tower, and blade servers; desktops; portable personal computers and t ablets; and software products, such as business application, operating system, entertainment, security, storage, and virtualization software products, as well as middleware and developer software tools. The company�s networking products comprise switches, hubs, routers, wireless local area networks, wireless wide area networks, network interface cards, cellular data cards, network-attached storage, and storage area networks; voice over Internet protocol, communications, modems, phone systems, and video/audio conferencing; and firewalls, virtual private networks, intrusion detection, and authentication devices and appliances. In addition, it provides integration, technical support, training, financial and credit, marketing, predictive analytics, eCommerce, reseller community hosting, managed, cloud, managed print, and professional services. The company sells its products to resellers through sales representatives. Ingram Micro Inc. was founded in 1979 and is headquartered in Santa Ana, California.
Advisors' Opinion:- [By Geoff Gannon]
A huge net-net like Ingram Micro (IM) with nine out of ten years of profits in the last decade is pretty unusual. And Ingram operates on a razor-thin margin. It usually makes about one cent in profit for every dollar of sales.
- [By Keith Speights]
My take is that Qualcomm has rapidly established itself as the de facto standard for connecting with medical devices. The company isn't doing it alone, though. It teamed with Ingram Micro (NYSE: IM ) , the world's largest technology distributor, to support the implementation, logistics, and financial services related to the 2net hub and platform. This partnership should help propagate Qualcomm's technology more effectively than the company could have done on its own.
- [By Jon C. Ogg]
The first list of 24/7 Wall St. stocks under book value for the month of August are Apache Corp. (NYSE: APA), Fresh Del Monte Produce Inc. (NYSE: FDP), Genworth Financial Inc. (NYSE: GNW), Ingram Micro Inc. (NYSE: IM) and JetBlue Airways Corp. (NASDAQ: JBLU). We generally have�focused on net asset values and tangible book values, as well as forward price-to-earnings multiples, share price performance, analyst expectations via the Thomson Reuters consensus price target and more.
Best Diversified Bank Companies To Invest In 2014: Axxess Pharma Inc (AXXE)
Axxess Pharma Inc. is a pharmaceutical company. It is engaged in marketing of dermatological, therapeutic nutritionals, pain management, and diagnostic products in Canada and abroad. In October 2013, the Company announced that it has incorporated a wholly owned subsidiary AllStar HealthBrands Inc.
The Company various products include Britical Tablets, Gravergol Capsules, Lactrase Capsules, Somnol Tablets, Triferexx -150 Polysaccharide-iron complex, Urasal Granules, Axspaz Tablets, Vivol Tablets, Hydraxx Lotion, Kemsol Solution, Soropon shampoo, and Skin care Products. Its distribution network includes physicians, hospitals, Government and defense institutions, and pharmacies.
Advisors' Opinion:- [By Peter Graham]
Small cap health care or personal care stocks Axxess Pharma Inc (OTCMKTS: AXXE), Radiant Creations Group Inc (OTCBB: RCGP) and Tauriga Sciences Inc (OTCMKTS: TAUG) have recently been attracting attention in various investment newsletters or in investor alerts. Some of the attention may have to do with paid promotions that two of these small caps have been the subject of. So how healthy are these three small cap health care or personal care orientated stocks? Here is a checkup:
- [By Peter Graham]
Small cap healthcare and lifestyle stocks Axxess Pharma Inc (OTCMKTS: AXXE), Medefile International Inc (OTCMKTS: MDFI) and Intelligent Living Inc (OTCMKTS: ILIV) have all been getting some extra attention lately thanks in part to a few disclosed paid promotions or investor relations type of activities. But just how healthy are these small cap stocks for investors and traders alike? Here is a quick reality check:
Axxess Pharma Inc (OTCMKTS: AXXE) Has Been Busy With the Press ReleasesSmall cap Axxess Pharma is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. On Friday, Axxess Pharma fell 7.52% to $0.295 for a market cap of $12.46 million plus AXXE is down 88.8% over the past year and down 99.8% over the past five years in intermittent trading according to Google Finance.
Best Diversified Bank Companies To Invest In 2014: Elan Corporation PLC (ELN)
Elan Corporation, plc (Elan), incorporated in December 1969, is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. Elan�� business focuses on neurodegenerative diseases, such as Alzheimer�� disease and Parkinson�� disease; autoimmune diseases, including MS and Crohn�� disease and neo-epitope based targets for treatments across a range of therapeutic indications. Tysabri is a treatment for MS and Crohn�� disease that the Company markets and distributes with Biogen Idec. On September 16, 2011, Elan sold its EDT business to Alkermes, Inc. In November 2011, Elan launched a collaboration with the University of Cambridge, England, the Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre). On December 21, 2012, the Company completed the demerger of Prothena Corporation plc. In April 2013, it closed the TYSABRI (natalizumab) Collaboration Transaction with Biogen Idec.
Tysabri
Tysabri, which is an alpha-4 integrin inhibitor, is a therapy for MS, a neurological disorder involving central nervous system dysfunction among adults. Tysabri is approved in more than 65 countries. Tysabri is approved in the United States as a monotherapy for relapsing forms of MS, for patients who have had an inadequate response to, or are unable to tolerate, an alternative MS therapy. In the European Union, it is approved for relapsing-remitting MS (RRMS) in adult patients who have failed to respond to beta interferon or have rapidly evolving, severe RRMS. As of December 31, 2011, there were approximately 64,400 patients on Tysabri therapy worldwide.
In June 2011, the European Commission (EC) approved the inclusion of the anti-JCV antibody status as an additional factor in stratifying patients at risk for developing PML in the Summary of Product Characteristics��(SmPC) for Tysabri in the European Union. The Company has developed a two-step ! enzyme-linked immunosorbent assay (ELISA), STRATIFY JCV, with Biogen Idec. The assay detects anti-JCV antibodies in the blood of patients, and is commercially available in Europe. In January 2012, the FDA cleared the assay for commercial use in the United States. As of December 31, 2011, over 80,000 tests had been administered using the assay. Tysabri is marketed and distributed by Elan and Biogen Idec. The Company�� research group, Neotope, is focused on creating monoclonal antibodies based on neo-epitope targets for the treatment of a range of therapeutic indications.
Beta Amyloid Immunotherapies (AIP)
Beta amyloid immunotherapy includes the treatment of Alzheimer�� disease by inducing or enhancing the body�� immune response in order to clear toxic species of beta amyloid from the brain. The AIP includes bapineuzumab (intravenous and subcutaneous delivery) and ACC-001, as well as other compounds. Bapineuzumab is an experimental humanized monoclonal antibody delivered intravenously that is being studied as a treatment for mild to moderate Alzheimer�� disease. It is designed to provide antibodies to beta amyloid directly to the patient (passive immunotherapy).
ELND005, an A� Aggregation Inhibitor
The small molecule ELND005 (Scyllo-inositol) is a beta amyloid anti-aggregation agent. Preclinical data suggest that ELND005 may act through the mechanism of preventing and reversing the fibrilisation of beta amyloid (the aggregation of beta amyloid into clumps of insoluble oligomers). ELND005 may have additional applications in psychiatric indications, such as bipolar disorder. In November 2011, the Company entered into a manufacturing agreement for the supply of the active pharmaceutical ingredient for ELND005 with Lonza Group AG.
Neotope Biosciences Limited
Neotope Biosciences Limited (Neotope) is the Company�� wholly owned subsidiary that focuses on the discovery and development of antibodies to neo-epitope related targ! ets for t! he treatment of a range of indications. It includes amyloidosis, diabetes, cancer and macular degeneration. Neotope�� portfolio of targets includes alpha-synuclein for the potential treatment of synucleinopathies, such as Lewy body dementia and Parkinson�� disease, tau for Alzheimer�� disease and other tauopathies. It also has a program for type 2-diabetes.
Onclave Therapeutics Limited
Elan�� wholly owned subsidiary Onclave Therapeutics Limited (Onclave) was formed to develop assets originating from Elan that have application in oncology related diseases. Onclave�� program, NEOD001, which originated from Neotope, is being investigated for the treatment of AL amyloidosis, which is a fatal disease involving abnormal accumulation of amyloid in organs and tissue. During the year ended December 31, 2011, Onclave filed for orphan drug designation of NEOD001. Onclave�� pipeline includes additional compounds with relevance in diverse cancer indications.
The Company competes with Biogen Idec, Bayer Schering Pharma AG, Bayer Schering Pharma, Merck Serono, Pfizer, Teva Neurosciences, Inc., Sanofi-Aventis and Novartis AG.
Advisors' Opinion:- [By Sean Williams]
Elan (NYSE: ELN )
Having a lot of cash in the biotech sector doesn't mean that a company's clinical trials will translate into success. Elan's claim to fame was the development of multiple sclerosis drug Tysabri, which it licensed out to Biogen Idec (NASDAQ: BIIB ) . Sales of the drug hit $1.6 billion last year. - [By Brian Orelli]
Most recently Elan (NYSE: ELN ) spun out its drug discovery business into Prothena. Without the burden of a drug discovery unit, the parent company is now being pursued by Royalty Pharma, although Elan isn't keen on its current offer.
Best Diversified Bank Companies To Invest In 2014: Tyson Foods Inc.(TSN)
Tyson Foods, Inc., together with its subsidiaries, engages in the production, distribution, and marketing of chicken, beef, pork, and prepared food products, as well as related allied products worldwide. The company?s Chicken segment involves in breeding and raising chickens, as well as processing live chickens into fresh, frozen, and value-added chicken products. Its Beef segment processes live fed cattle and fabricates dressed beef carcasses into primal and sub-primal meat cuts and case-ready products The company?s Pork segment involves in the processing live market hogs; and fabricating pork carcasses into primal and sub-primal cuts and case-ready products. Its Prepared Foods segment manufactures and markets frozen and refrigerated food products comprising pepperoni, bacon, beef and pork pizza toppings, pizza crusts, flour and corn tortilla products, appetizers, prepared meals, ethnic foods, soups, sauces, side dishes, meat dishes, and processed meats. The company mark ets and sells its products to grocery retailers, grocery wholesalers, meat distributors, warehouse club stores, military commissaries, industrial food processing companies, chain restaurants or their distributors, international export companies, and domestic distributors, as well as to foodservice operations, such as plant and school cafeterias, convenience stores, hospitals, and other vendors. Tyson Foods, Inc. also offers its allied products to the manufacturers of pharmaceuticals and technical products, as well as to pork processors. The company was founded in 1935 and is headquartered in Springdale, Arkansas.
Advisors' Opinion:- [By Ben Levisohn]
What is it with food stocks this week? Tyson Foods (TSN) releases earnings on Monday and gains 7.5% through today. Campbell Soup (CPB) releases on Tuesday and falls 6.2%. And now JM Smucker (SJM) releases its own results and has experienced a big move of its own–a plunge.
Bloomberg NewsThe Wall Street Journal has the details on JM Smucker’s earnings:
For the period ended Oct. 31, Smucker reported a profit of $153.4 million, or $1.46 a share, up from $148.8 million, or $1.36 a share, a year earlier. Excluding restructuring, integration and other costs, per-share earnings improved to $1.52 from $1.45.
Analysts polled by Thomson Reuters most recently forecast earnings of $1.60 a share on revenue of $1.61 billion.
Gross margin widened to 35.4% from 33.3%…
Known for its namesake fruit spreads and peanut butter, as well as Jif brand peanut butter, Smucker also lowered its sales guidance for the year, now predicting a decline of about 2% from last year, versus its earlier forecast for a 1% drop. The company backed its earnings guidance.
Janney’s Jonathan Feeney and Mark Williams look at the bright side:
We recognize that the coffee category, where Smucker is getting more than all of its growth, is currently under a three-fold siege: 1) the decline in coffee costs and associated promotional activity, 2) the impact of the growth of K-Cups on bag and can retail coffee, and 3) the entrance of several players to the K-Cup universe ��which have now apparently eliminated a big growth (+250 million or +2% annualized) tailwind for Smucker since FY 2011. That said, we see the significant likely ($6+) and growing cash flow at SJM ��in a world paying enormous multiples for yield of all kinds ��as too much to pass up. Specifically, SJM trades at a roughly 10% discount on cash EPS to peers due to these uncertainties, in a group that has plenty of uncertainties of its own. While organic top-line growt
Best Diversified Bank Companies To Invest In 2014: Intuit Inc.(INTU)
Intuit Inc. provides business and financial management solutions for small and medium-sized businesses, consumers, accounting professionals, and financial institutions primarily in the United States, Canada, India, Singapore, and the United Kingdom. The company offers QuickBooks financial and business management software and services, technical support, financial supplies, and Web site design and hosting services for small and medium-sized businesses; and payroll products and services, as well as merchant services comprising credit and debit card processing, electronic check conversion, and automated clearing house services for small businesses. It also provides TurboTax income tax preparation products and services for consumers and small business owners; Lacerte and ProSeries professional tax products and services; and QuickBooks Premier Accountant Edition and the QuickBooks ProAdvisor Program for accounting professionals. In addition, the company offers outsourced online financial management solutions for banks and credit unions; Quicken personal finance products and services; Mint.com online personal finance services; and Intuit Health online patient-to-provider communication solutions. It sells its products and services through various sales and distribution channels, including Websites, promotions, retail channels, and call centers, as well as through alliance partners, principally consisting of banks, credit unions, and securities and investment firms. The company was founded in 1983 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Motley Fool Staff]
In this video segment, Remer describes the platforms and ecosystems in use for money transfer, how they're evolving with each generation, and what he sees ahead for current giants such as MasterCard (NYSE: MA ) , Intuit (NASDAQ: INTU ) , and eBay (NASDAQ: EBAY ) .
- [By Rich Smith]
ADP stock is worse than average
ADP shares have been on a bit of a tear these past 12 months, outperforming not just the S&P 500 in general, but also rivals Paychex (NASDAQ: PAYX ) and Intuit (NASDAQ: INTU ) in particular. It's a bit of a mystery, however, understanding why investors like ADP stock so much. - [By Maria Armental and Tess Stynes var popups = dojo.query(".socialByline .popC"); ]
Intuit Inc.'s(INTU) fiscal third-quarter profit rose 20% as the tax software company recorded higher revenues, bolstered by a late start to tax season. However its fiscal year outlook was slightly below expectations. Shares fell 4.7% to $73.20 premarket.
- [By Mani]
Intuit Inc. (NASDAQ: INTU) is slated to report its first quarter financial results on�Nov.21. The company will host a conference call on the same day at 1.30 Pacific Time to discuss the operating performance.
Best Diversified Bank Companies To Invest In 2014: Transglobe Energy Corp(TGA)
TransGlobe Energy Corporation operates as an exploration and production company with oil interests in the Arab Republic of Egypt and the Republic of Yemen. It has interests in 9 international blocks comprising 5.5 million acres. The company was formerly known as Dusty Mac Mines, Ltd. and changed its name to TransGlobe Energy Corporation in April 1996 as a result of its business focus shift from mineral exploration and extraction to oil and gas business. TransGlobe Energy Corporation was founded in 1968 and is headquartered in Calgary, Canada.
Advisors' Opinion:- [By Sean Williams]
Overseas opportunity
I can't say I'm someone who particularly likes to push my luck in regions of the world where political upheaval can threaten my investments. One such example where I've bucked that trend is AngloGold Ashanti�in Africa, which dealt with a large labor strike that shut down two its mines for a significant amount of time. This came on top of the higher-than-normal labor costs African metal miners already deal with. The next such name I'd like to add to this short list of exceptions is independent oil and gas driller TransGlobe Energy (NASDAQ: TGA ) . - [By Seth Jayson]
TransGlobe Energy (Nasdaq: TGA ) is expected to report Q1 earnings on May 7. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict TransGlobe Energy's revenues will contract -10.7% and EPS will expand 80.0%.
No comments:
Post a Comment